Ciclopirox
Generic name
Ciclopirox
Brand name
ATC Code
D01AE14
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No data available.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Dermatophytosis |
|---|
|
Renal impaiment in children > 3 months
Dose adjustment not needed
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIFUNGALS FOR TOPICAL USE
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antibiotics | ||
|---|---|---|
| D01AA01 | ||
| Imidazole and triazole derivatives | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC20 | ||
| D01AC09 | ||
| Other antifungals for topical use | ||
|---|---|---|
| D01AE13 | ||
| D01AE15 | ||
| IMIDAZOLE AND TRIAZOLE DERIVATIVES | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC20 | ||
| D01AC09 | ||
| OTHER ANTIFUNGALS FOR TOPICAL USE | ||
|---|---|---|
| D01AE13 | ||
| D01AE15 | ||
References
- Stary, H., et al, Ciclopiroxolamine (Batrafen®) for Topical Treatment of Dermatomycoses in Infants and Small Children., Medi-A-DERM, 1990, 1/90, 3-13
- Kligman, A.M., Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies., Clin Ther, 1985, 7(4), 409-17
- Gomez-Moyano, E. et al, Phase III study of the efficacy and safety of ciclopirox olamine cream in small children with dermatomycosis, Rev Iberoam Micol, 2015, 32(3), 164-9
Changes
Therapeutic Drug Monitoring
Overdose
